{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:40:48Z","timestamp":1779392448380,"version":"3.53.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"DOI":"10.7759\/cureus.79198","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:21:14Z","timestamp":1739866874000},"source":"Crossref","is-referenced-by-count":1,"title":["New Delhi Metallo-Beta-Lactamases (NDM)-Carbapenem-Resistant Acinetobacter baumannii Pneumonia: A Case Report"],"prefix":"10.7759","author":[{"given":"Siddartha","family":"Guru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navami","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimoona","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoll","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"Yong D","year":"2009","unstructured":"Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009, 53:5046-54. 10.1128\/AAC.00774-09","journal-title":"Antimicrob Agents Chemother"},{"key":"ref2","unstructured":"ARLN explorer. (2025). Accessed. February 4, 2025: https:\/\/arpsp.cdc.gov\/arln-explorer."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.092","article-title":"Molecular epidemiology of NDM-producing Acinetobacter baumannii in the US\u2014October 2013\u2014March 2022","volume":"10","author":"Medrzycki M","year":"2023","unstructured":"Medrzycki M, Stanton RA, Rankin DA, et al.. Molecular epidemiology of NDM-producing Acinetobacter baumannii in the US\u2014October 2013\u2014March 2022. Open Forum Infect Dis. 2023, 10:ofad500.092. 10.1093\/ofid\/ofad500.092","journal-title":"Open Forum Infect Dis"},{"key":"ref4","unstructured":"LHD IP forum course highlights. NDM-CRAb outbreak in California. (2023). Accessed: February 4, 2025: https:\/\/www.cdph.ca.gov\/Programs\/CHCQ\/HAI\/CDPH%20Document%20Library\/LHD_IP_ForumCourseHighlights_NDM-CRAB_OutbreakInC...."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma PD","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin Infect Dis. 2024, ciae403. 10.1093\/cid\/ciae403","journal-title":"Clin Infect Dis"},{"key":"ref6","article-title":"Acinetobacter species","author":"Hochman S","year":"2020","unstructured":"Hochman S, Phillips M. Acinetobacter species. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 222nd ed. . Bennett JE, Dolin R, Blaser MJ (ed): Elsevier, Netherlands; 2020. 2718-24."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee CR","year":"2017","unstructured":"Lee CR, Lee JH, Park M, et al.. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017, 7:55. 10.3389\/fcimb.2017.00055","journal-title":"Front Cell Infect Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01981-23","article-title":"Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021","volume":"11","author":"Pfaller MA","year":"2023","unstructured":"Pfaller MA, Shortridge D, Carvalhaes CG, Castanheira M. Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021. Microbiol Spectr. 2023, 11:e0198123. 10.1128\/spectrum.01981-23","journal-title":"Microbiol Spectr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/249856","article-title":"Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria","volume":"2014","author":"Dortet L","year":"2014","unstructured":"Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int. 2014, 2014:249856. 10.1155\/2014\/249856","journal-title":"Biomed Res Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-24534","article-title":"Enzyme patterns and factors associated with mortality among patients with carbapenem resistant Acinetobacterbaumannii (crab) bacteremia: real world evidence from a tertiary center in India","volume":"27","author":"Prayag PS","year":"2023","unstructured":"Prayag PS, Patwardhan SA, Joshi RS, Panchakshari SP, Rane T, Prayag AP. Enzyme patterns and factors associated with mortality among patients with carbapenem resistant Acinetobacterbaumannii (crab) bacteremia: real world evidence from a tertiary center in India. Indian J Crit Care Med. 2023, 27:663-8. 10.5005\/jp-journals-10071-24534","journal-title":"Indian J Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-24834","article-title":"The clinical impression of NDM-producing Acinetobacter baumannii in intensive care units of the University Referral Hospital in North India","volume":"28","author":"Singh S","year":"2024","unstructured":"Singh S, Verma A, Venkatesh V, Verma S, Reddy DH, Agrawal A. The clinical impression of NDM-producing Acinetobacter baumannii in intensive care units of the University Referral Hospital in North India. Indian J Crit Care Med. 2024, 28:1044-9. 10.5005\/jp-journals-10071-24834","journal-title":"Indian J Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13080","article-title":"Cefiderocol-based regimen for Acinetobacter NDM-1 outbreak","volume":"13","author":"Travi G","year":"2024","unstructured":"Travi G, Peracchi F, Merli M, et al.. Cefiderocol-based regimen for Acinetobacter NDM-1 outbreak. Antibiotics (Basel). 2024, 13:770. 10.3390\/antibiotics13080","journal-title":"Antibiotics (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti M","year":"2021","unstructured":"Bassetti M, Echols R, Matsunaga Y, et al.. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet. 2021, 21:226-40. 10.1016\/S1473-3099","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343348-new-delhi-metallo-beta-lactamases-ndm-carbapenem-resistant-acinetobacter-baumannii-pneumonia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:21:16Z","timestamp":1739866876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343348-new-delhi-metallo-beta-lactamases-ndm-carbapenem-resistant-acinetobacter-baumannii-pneumonia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.79198","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}